Komori
Results4172Hi-CRATES CO.,LTD.Information and Communications, Services and Others

Financial Results for the Fiscal Year Ending September 2026 (Japanese GAAP, Non-Consolidated)

For the fiscal year ended September 2026, revenue increased 4.5% year on year and operating profit increased 3.5%, while ordinary profit and net income also rose. For the fiscal year ending September 2027, the company expects higher revenue and profits and has raised its annual dividend forecast from the previous fiscal year's actual dividend of ¥94 to ¥100.

Worth reading
37Immaterial
Scored from 4 of 6 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
4.5
Year-on-year change in net sales (%)
Wording
Conditional
How definitive the wording is.

Results for this period

Full year1 October 2025 to 30 September 2026Non-consolidated (standalone)Japanese GAAP
Net Sales2,516¥ millionYear on year +4.5%Progress 98.7%
Operating profit568¥ millionYear on year +3.5%Progress 98.4%
Ordinary income726¥ millionYear on year +11.4%Progress 99.9%
Net income attributable to owners of the parent495¥ millionYear on year +10.6%Progress 99.6%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥222.40
Operating Margin22.6%
Financial position at period-end
Total assets5,147¥ million
of which net assets 4,480 ¥ millionEquity ratio 87.1%vs. prior year-end -1.8pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Cash inflows and outflows
Operating+553
Investment+1,017
Financials-206
Net change+1,364

Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.

Cash and cash equivalents at end of period¥2,467 million
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥2,550 million (YoY +1.4%)
Operating profit¥577 million (YoY +1.6%)
Ordinary income¥727 million (YoY +0.1%)
Net income¥497 million (YoY +0.5%)
Annual Dividend Forecast94 yen → 100 yen(+6.4%)
Payout ratio42.3%
Factors Behind Changes in Business Performance

The company strengthened consulting sales aimed at expanding clinic revenue through management transformation and focused on expanding sales centered on AI and voice-enabled electronic medical records.

Disclosure regarding the going concern assumption

Not applicable

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Material subsequent eventsNo applicable items
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of fixed assets ¥3,833 thousand / Extraordinary loss Loss on disposal of fixed assets ¥0 thousand
Depreciation and amortization¥104,341 thousand
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingYes (for individual investors)
Issued Shares at Period-End2,228,000 shares
Treasury Shares at Period-End165 shares
Results for this period
ItemDetails
Fiscal Period ClassificationFull year
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedNon-consolidated (standalone)
Period Covered1 October 2025 to 30 September 2026
Net Sales¥2,516 million (YoY +4.5%)
Operating profit¥568 million (YoY +3.5%)
Ordinary income¥726 million (YoY +11.4%)
Profit attributable to owners of the parent¥495 million (YoY +10.6%)
Net income per share¥222.40
Operating Margin22.6%
Equity ratioEnd of the current fiscal period 87.1% / End of previous period 88.9%
Total assets¥5,147 million
Net assets¥4,480 million
Cash flows from operating activities¥553 million
Cash flows from investing activities¥1,017 million
Cash flows from financing activities¥-206 million
Cash and cash equivalents at end of period¥2,467 million
Full-year earnings forecastNet Sales ¥2,550 million (YoY +1.4%) / Operating profit ¥577 million (YoY +1.6%) / Ordinary income ¥727 million (YoY +0.1%) / Net income ¥497 million (YoY +0.5%)
Annual Dividend Forecast94 yen → 100 yen(+6.4%)
Payout ratio42.3%
Depreciation and amortization¥104,341 thousand
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of fixed assets ¥3,833 thousand / Extraordinary loss Loss on disposal of fixed assets ¥0 thousand
Disclosure regarding the going concern assumptionNot applicable
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No
Material subsequent eventsNo applicable items
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingYes (for individual investors)
Issued Shares at Period-End2,228,000 shares
Treasury Shares at Period-End165 shares
Factors Behind Changes in Business PerformanceThe company strengthened consulting sales aimed at expanding clinic revenue through management transformation and focused on expanding sales centered on AI and voice-enabled electronic medical records.
Items this document does not state (8)
Revision to Earnings ForecastShareholder Return PolicySegment revenueSegment profitRegional salesOrders received and order backlogImpairment lossChanges in the scope of consolidation

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

This resulted from strengthening consulting sales and focusing on expanding sales centered on AI and voice-enabled electronic medical records.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.